memantine has been researched along with Acute Relapsing Multiple Sclerosis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition, many adverse reactions were observed in these patients." | 2.82 | Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study. ( Brassat, D; Brochet, B; Cabre, P; Castelnovo, G; Clavelou, P; Coman, I; Creveuil, C; Daplaud, D; De Seze, J; Debouverie, M; Defer, G; Dupuy, B; Hautecoeur, P; Heinzlef, O; Lebiez, P; Lebrun-Frenay, C; Pelletier, J; Peyro Saint Paul, L; Sartori, É; Tourbah, A; Vermersch, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peyro Saint Paul, L | 1 |
| Creveuil, C | 1 |
| Heinzlef, O | 1 |
| De Seze, J | 1 |
| Vermersch, P | 1 |
| Castelnovo, G | 1 |
| Cabre, P | 1 |
| Debouverie, M | 1 |
| Brochet, B | 1 |
| Dupuy, B | 1 |
| Lebiez, P | 1 |
| Sartori, É | 1 |
| Clavelou, P | 1 |
| Brassat, D | 1 |
| Lebrun-Frenay, C | 1 |
| Daplaud, D | 1 |
| Pelletier, J | 1 |
| Coman, I | 1 |
| Hautecoeur, P | 1 |
| Tourbah, A | 1 |
| Defer, G | 1 |
| Villoslada, P | 1 |
| Arrondo, G | 1 |
| Sepulcre, J | 1 |
| Alegre, M | 1 |
| Artieda, J | 1 |
| Green, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Memantine on Cognitive Disorders of Relapsing-remitting Multiple Sclerosis[NCT01074619] | Phase 3 | 90 participants (Actual) | Interventional | 2005-09-30 | Completed | ||
| Pilot Clinical Trial With Memantine for Cognitive Deficits in Patients With Multiple Sclerosis[NCT00638833] | Phase 2 | 20 participants (Actual) | Interventional | 2007-09-30 | Terminated (stopped due to Unexpected side-effects: reversible and mild to moderate neurological impairment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for memantine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study.
Topics: Adult; Cognition Disorders; Dizziness; Double-Blind Method; Excitatory Amino Acid Antagonists; Femal | 2016 |
Memantine induces reversible neurologic impairment in patients with MS.
Topics: Brain; Cognition Disorders; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, D | 2009 |
1 other study available for memantine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Understanding pseudo: the symptoms are real, the cause is unclear.
Topics: Brain; Chemotaxis, Leukocyte; Clinical Trials as Topic; Encephalitis; Excitatory Amino Acid Antagoni | 2009 |